Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' (Deficit) Equity

v3.6.0.2
Consolidated Statements of Changes in Shareholders' (Deficit) Equity - USD ($)
$ in Millions
Total
Common Shares [Member]
Paid-in Capital in Excess of par Value [Member]
Accumulated Other Comprehensive Loss [Member]
(Accumulated Deficit) Retained Earnings [Member]
Beginning Balance at Dec. 31, 2013 $ 551.4 $ 0.1 $ 323.9 $ (19.8) $ 247.2
Issuance of 1.4 million, 1.0 million and 0.6 million common shares from exercise of stock options, SARs, restricted stock units, and employee stock purchase plan, and other, in 2014, 2015 and 2016 respectively 0.7   0.7    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 10.4   10.4    
Additional capital from share based compensation 45.7   45.7    
Repurchases of 20.2 million, 0.4 million and 0.2 million common shares, inclusive of the Forward Transactions in 2014, 2015 and 2016 respectively (1,291.9)   (97.6)   (1,194.3)
Dividends paid and dividend equivalents ($0.30 per share) (30.4)       (30.4)
Dividends received 3.4       3.4
Issuance of the convertible notes and forward transaction 249.8   249.8    
Payments for capped call transactions (123.8)   (123.8)    
Net income 308.7       308.7
Foreign currency translation adjustment, net of income taxes of $(7.3), $(7.2) and $5.2 in 2014, 2015 and 2016 respectively (70.8)     (70.8)  
Unrealized gain/ (loss) on derivatives, net of income taxes of $0.6, $(0.6) and $(0.3) in 2014, 2015 and 2016 respectively 12.3     12.3  
Unrealized gain/ (loss) on available-for-sale investments, net of income taxes of $0.1, $(0.1) and $0.1 in 2014, 2015 and 2016 respectively 0.1     0.1  
Ending Balance at Dec. 31, 2014 (334.4) 0.1 409.1 (78.2) (665.4)
Issuance of 1.4 million, 1.0 million and 0.6 million common shares from exercise of stock options, SARs, restricted stock units, and employee stock purchase plan, and other, in 2014, 2015 and 2016 respectively 2.8   2.8    
Excess tax deficit from exercise of stock options, SARs and restricted stock grants (2.0)   (2.0)    
Additional capital from share based compensation 44.9   44.9    
Repurchases of 20.2 million, 0.4 million and 0.2 million common shares, inclusive of the Forward Transactions in 2014, 2015 and 2016 respectively (16.6)   (16.6)    
Net income 339.1       339.1
Foreign currency translation adjustment, net of income taxes of $(7.3), $(7.2) and $5.2 in 2014, 2015 and 2016 respectively (86.6)     (86.6)  
Unrealized gain/ (loss) on derivatives, net of income taxes of $0.6, $(0.6) and $(0.3) in 2014, 2015 and 2016 respectively (0.6)     (0.6)  
Unrealized gain/ (loss) on available-for-sale investments, net of income taxes of $0.1, $(0.1) and $0.1 in 2014, 2015 and 2016 respectively (0.1)     (0.1)  
Ending Balance at Dec. 31, 2015 (53.5) 0.1 438.2 (165.5) (326.3)
Issuance of 1.4 million, 1.0 million and 0.6 million common shares from exercise of stock options, SARs, restricted stock units, and employee stock purchase plan, and other, in 2014, 2015 and 2016 respectively 2.0   2.0    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 0.4   0.4    
Additional capital from share based compensation 40.2   40.2    
Repurchases of 20.2 million, 0.4 million and 0.2 million common shares, inclusive of the Forward Transactions in 2014, 2015 and 2016 respectively (13.2)   (13.2)    
Net income 260.0       260.0
Foreign currency translation adjustment, net of income taxes of $(7.3), $(7.2) and $5.2 in 2014, 2015 and 2016 respectively (32.5)     (32.5)  
Unrealized gain/ (loss) on derivatives, net of income taxes of $0.6, $(0.6) and $(0.3) in 2014, 2015 and 2016 respectively (7.0)     (7.0)  
Unrealized gain/ (loss) on available-for-sale investments, net of income taxes of $0.1, $(0.1) and $0.1 in 2014, 2015 and 2016 respectively (0.1)     (0.1)  
Ending Balance at Dec. 31, 2016 $ 196.3 $ 0.1 $ 467.6 $ (205.1) $ (66.3)